PURE Bioscience, Inc., formerly PURE Bioscience, is engaged in the development and commercialization of bioscience technologies. Its flagship bioscience technology is a aqueous antimicrobial called silver dihydrogen citrate (SDC). A molecular entity, SDC is an electrolytically generated source of stabilized ionic silver, which serves as the basis for a range of products in diverse markets. SDC liquid is colorless, odorless, tasteless, non-caustic and formulates well with other compounds. The Company is producing pre-formulated, ready-to-use products for both its own brands and for private label distribution, as well as varying strengths of SDC concentrate as an additive or raw material for inclusion in other companies� products. It is also producing SDC as an active pharmaceutical ingredient, which is in clinical trials for multiple indications. In addition to SDC, it has obtained protection for ionic silver-based molecular entities utilizing 14 organic acids other than citric acid.